Phase I clinical trial of CD19‐targeted 19‐28z/4‐1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter transformation Meeting Abstract


Authors: Batlevi, C. L.; Palomba, M. L.; Park, J.; Mead, E.; Santomasso, B.; Riviere, I.; Wang, X.; Senechal, B.; Furman, R.; Yang, J.; Kane, P.; Hall, M.; Bernal, Y.; Lund, N.; Diamonte, C.; Pineda, J.; Halton, E.; Moskowitz, C.; Younes, A.; Sadelain, M.; Brentjens, R.
Abstract Title: Phase I clinical trial of CD19‐targeted 19‐28z/4‐1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter transformation
Meeting Title: 15th International Conference on Malignant Lymphoma
Journal Title: Hematological Oncology
Volume: 37
Issue: Suppl. 2
Meeting Dates: 2019 Jun 18-22
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2019-06-01
Start Page: 166
End Page: 167
Language: English
ACCESSION: 136932426
DOI: 10.1002/hon.124_2629
PROVIDER: EBSCOhost
PROVIDER: cin20
PUBMED: 31187525
DOI/URL:
Notes: Meeting Abstract: 118 -- Source: cin20
Altmetric Score
MSK Authors
  1. Renier J Brentjens
    208 Brentjens
  2. Maria Lia Palomba
    145 Palomba
  3. Jae Hong Park
    156 Park
  4. Elizabeth F Halton
    27 Halton
  5. Michel W J Sadelain
    472 Sadelain
  6. Isabelle C Riviere
    176 Riviere
  7. Xiuyan Wang
    75 Wang
  8. Yvette J Bernal
    26 Bernal
  9. Connie Wing-Ching Lee
    58 Lee
  10. Anas Younes
    222 Younes
  11. Elena   Mead
    22 Mead
  12. Malloury W Hall
    3 Hall
  13. Peter T Kane
    2 Kane
  14. John Pineda
    3 Pineda
  15. Nisha Lund
    1 Lund
Related MSK Work